Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats

Renal Failure

Volumn 31, Issue 1, 2009, Pages 54-61

  Stojiljkovic, Nenad ^a   Veljkovic, Slavimir ^a   Mihailovic, Dragan ^a   Stoiljkovic, Milan ^a   Radenkovic, Mirjana ^a   Rankovic, Goran ^a   Randjelovic, Pavle ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Gentamicin; Morphometry; Nephrotoxicity; Pentoxifylline; Rats

Indexed keywords

CREATININE; EOSIN; GENTAMICIN; HEMATOXYLIN; PENTOXIFYLLINE; POTASSIUM; SODIUM; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; BLOOD CLOTTING; CELL VACUOLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; EXPERIMENTAL MODEL; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HISTOLOGY; KIDNEY PROXIMAL TUBULE; MALE; MORPHOMETRICS; NEPHROTOXICITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OPTICAL DENSITY; PERIODIC ACID SCHIFF STAIN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RAT; RENAL PROTECTION; SODIUM BLOOD LEVEL; STAINING; UREA BLOOD LEVEL;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD UREA NITROGEN; CREATININE; GENTAMICINS; KIDNEY FAILURE, ACUTE; MALE; PENTOXIFYLLINE; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 61649085212     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802546321     Document Type: Article

References (49)

1. Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: Nephrotoxicity. Antimicrob Agents Chemother. 1999;43:1003-1012.
2. Gilbert N. Aminoglycosides. In Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. 5th ed. New York: Churchill Livingstone; 2000:307-336.
3. Erdem A, Gundogan NU, Usubutun A, et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol Dial Transplant. 2000;15(8):1175-1182.
4. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: Activity and resistance. Antimicrob Agents Chemother. 1999;43:727-737.
5. De Rougemont D, Oeschger A, Konrad L. Gentamicin-induced acute renal failure in the rat. Effect of dehydration, DOCA-saline and furosemide. Nephron. 1981;29(3-4):176-184.
6. Ali BH. Gentamicin nephrotoxicity in humans and animals: Some recent research. Gen Pharmac. 1995;26(7):1477-1487.
7. Ali BH. Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: Some recent research. Food Chem Toxicol. 2003;41:1447-1452.
8. Cojocel C, Docius N, Maita K, Smith JH, Hook JB. Renal ultrastructural and biochemical injuries induced by aminoglycosides. Environ Health Perspect. 1984;57:293-299.
9. Stojiljkovic N, Veljković S, Mihailović D, Stoiljković M, Radovanović D, RanCrossed d signelović P. The effect of calcium channel blocker verapamil on gentamicin nephrotoxicity in rats. Bosn J Basic Med Sci. 2008;8(2):170-176.
10. Veda N, Maycux PR, Baliga R, Shah SV. Oxidant mechanisms in acute renal failure. In: Molitoris BA, Finn WF, eds. Acute renal failure: A companion to Brenner and Recter's. The Kidney. Philadelphia: W.B. Saunders Company Press; 2001:60-77.
11. Martinez-Salgado C, Eleno N, Tavares P, et al. Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation. Kidney Int. 2002;62:1682-1692.
12. Laurent G, Maldague P, Carlier MB, Tulkens PM. Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob Agents Chemother. 1983;24(4):586-593.
13. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med. 1999;189:381-394.
14. Moudden M, Laurent G, Leclercq M, Tulkens P. Gentamicin induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicological Sciences. 2000;56:229-239.
15. Kopple JD, Ding H, Letoha A, et al. L-carnitine ameliorates gentamicin-induced renal injury in rats. Nephrol Dial Transplant. 2002;17(12):2122-2131.
16. Pedraza-Chaverry J, Gonzalez-Orozcoa AE, Maldonado PD, Barrera D, Medina-Campos ON, Hernandez-Pando R. Diallyl disulfide ameliorates gentamicin induced oxidative stress and nephropaty in rats. Eur J Pharmacol. 2003;473:71-78.
17. Parlakpinar H, Tasdemir S, Polat A, et al. Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochem Funct. 2006;24(1):41-48.
18. Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S. Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2001;424:75-83.
19. Laurent G, Carlier MB, Rollman B, Van Hoof F, Tulkens P. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: In vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol. 1982;31:3861-3870.
20. Sundin DP, Sandoval R, Molitoris BA. Gentamicin inhibits renal protein and phospholipid metabolism in rats: Implications involving intracellular trafficking. J Am Soc Nephrol. 2001;12:114-123.
21. Wasan KM, Vadiei K, Lopez-Berestein G, Verani RR, Luke DR. Pentoxifylline in amphotericin B toxicity rat model. Antimicrob Agents Chemother. 1990;34:241-244.
22. Bianco JA, Almgren J, Kern DL, et al. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Transplantation. 1991;51:925-927.
23. Vadiei K, Brunner LJ, Luke DR. Effects of pentoxifylline in experimental acute renal failure. Kidney Int. 1989;36:466-470.
24. Aviado DM, Porter JM. Pentoxifylline: A new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy. 1984;4:297-307.
25. Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (α) on neutrophil function by pentoxifylline. Infect Immun. 1988;56:1722-1729.
26. Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology. 1993;187:447-463.
27. Muller R, Lebrach F. Hemorheological role of platelet aggregation and hypercoagulability in microcirculation: Therapeutical approach with pentoxifylline. Pharmatherapeutica. 1980;2:372-379.
28. Marukawa S, Hatake K, Wakabayashi I, Hishida S. Vasorelaxant effects of oxpentifylline and theophylline on rat isolated aorta. J Pharm Pharmacol. 1994;46:342-345.
29. Poggesi L, Scarti L, Boddi M, Masotti G, Serneri GG. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis. Angiology. 1985;36:628-637.
30. Horvath B, Marton Z, Halmosi R, et al. In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine. Clin Neuropharmacol. 2002;25(1):37-42.
31. Bhat VB, Madyastha KM. Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem Biophys Res Commun. 2001;288(5):1212-1217.
32. Stojiljkovic N, Mihailovic D, Veljkovic S, Stoiljkovic M, Jovanovic I. Glomerular basement membrane alterations induced by gentamicin administration in rats. Exp Toxicol Pathol. 2008;60:69-75.
33. Wiland P, Szechcinski J. Proximal tubule damage in patients treated with gentamicin or amikacin. Pol J Pharmacol. 2003;55:631-637.
34. Cuzzocrea S, Mazzon E, Dugo L, et al. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2002;450:67-76.
35. Maldonado PD, Barrera D, Medina-Campos ON, Hernandez-Pando R, Ibarra-Rubio ME, Pedraza-Chaverri J. Aged garlic extract attenuates gentamicin-induced renal damage and oxidative stress in rats. Life Sci. 2003;73(20):2543-2556.
36. Atessahin A, Karahan I, Yilmaz S, Ceribasi AO, Princci I. The effect of manganese chloride on gentamicine-induced nephrotoxicity in rats. Pharmacol Res. 2003;48:637-642.
37. Nakajima T, Hishida A, Kato A. Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am J Physiol. 1994;266(3 Pt 2):425-431.
38. Abdel-Naim AB, Abdel-Wahab MH, Attia FF. Protective effects of vitamin E and probucol against gentamicin-induced nephrotoxicity in rats. Pharmacol Res. 1999;40(2): 183-187.
39. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999;31(4):971-997.
40. Matsuda O, Beck FX, Dorge A, Thurau K. Electrolyte composition of renal tubular cells in gentamicin nephrotoxicity. Kidney Int. 1988;33:1107-1112.
41. Tulkens PM, Mingeot-Leclercq MP, Laurent G, Brasseur R. Conformational and biochemical analysis of the interactions between phospholipids and aminoglycoside antibiotics in relation with their toxicity. In Brasseur R, ed. Molecular description of biological membrane components by computer-aided conformational analysis. Boca Raton, Fla.: CRC Press Inc.; 1990: 63-93.
42. Brunner LJ, Vadiei K, Iyer LV, Luke DR. Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline. Ren Fail. 1989;11(2-3):97-104.
43. Akpolat T, Akpolat I, Ozturk H, et al. Effect of vitamin E and pentoxifylline on glycerol-induced acute renal failure. Nephron. 2000;84(3):243-247.
44. Kim YK, Choi TR, Kwon CH, Kim JH, Woo JS, Jung JS. Beneficial effect of pentoxifylline on cisplatin-induced acute renal failure in rabbits. Ren Fail. 2003;25(6):909-922.
45. Strutz F, Ziesberg M, Hemmerlein B. Basic fibroblast growth factor (FGF-2) expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int. 2000;57:1521-1538.
46. Kaputlu I, Sadan G, Karayalcin B, Boz A. Beneficial effects of pentoxifylline on cyclosporine-induced nephrotoxicity. Clin Exp Pharmacol Physiol. 1997;24(5):365-369.
47. Savic V, Vlahovic P, Djordjevic V, Mitic-Zlatkovic M, Avramovic V, Stefanovic V. Nephroprotective effects of pentoxifylline in experimental myoglobinuric acute renal failure. Pathol Biol. 2002;50(10):599-607.
48. Vadiei K, Brunner LJ, Luke DR. Effects of pentoxifylline in experimental acute renal failure. Kidney Int. 1989;36(3):466-470.
49. Ellory JC, Culliford SJ, Honvitz ER, Mojiminiyi FBO, Stuart J. Oxpentifylline-induced inhibition of calcium entry into human erythrocytes. Clin Hemorheol. 1994;14:545-555.